Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1772238

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1772238

Middle East & Africa Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Type (Appliers, Accessories), By Connectivity, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4250
Printable PDF & Excel (5-User License)
USD 5250
Printable PDF & Excel (Enterprise License)
USD 7250

Add to Cart

Market Size & Trends:

The Middle East & Africa continuous glucose monitoring devices market size was estimated at USD 391.7 million in 2024 and is expected to grow at a CAGR of 11.8% from 2025 to 2033 to reach a value of USD 1,072.2 million in 2033. This growth is fueled by the alarming rise in diabetes cases across the region. In the Middle East and North Africa (MENA), the number of adults aged 20-79 with diabetes increased from 17 million in 2000 to 84.7 million in 2024 and is expected to reach 162.6 million by 2050. MENA has the world's highest regional prevalence at 17.6% and a projected 92% surge in cases.

In support of increasing access to continuous glucose monitoring (CGM) technologies, the Foundation for Innovative New Diagnostics (FIND) launched the "Access to CGMs for Equity in Diabetes Management" (ACCEDE) initiative, seeking proposals from CGM manufacturers not yet commercialized in Kenya and South Africa. As of early 2023, only about 10% of the 55,000 people living with type 1 diabetes in these countries were using CGMs. Furthermore, rising insulin use among type 2 diabetes patients-estimated at 18% in Kenya and up to 45% in South Africa's private sector-presents a significant opportunity for CGM expansion.

FIND's strategy aims to double CGM usage in Kenya and South Africa by 2025 and extend reach to an estimated regional market of 213,000 type 1 and 21.5 million type 2 diabetes patients across Eastern and Southern Africa. The project emphasizes affordability, training, and evidence generation to ensure scalable and sustainable CGM adoption. CGM devices provide continuous, real-time glucose data, supporting better glycemic control and reducing the need for invasive fingersticks. However, their effectiveness depends heavily on proper patient training and healthcare provider support.

Safety concerns linked to CGM misuse, particularly from insufficient training, have been highlighted in recent evaluations. A cross-sectional study in Saudi Arabia showed that 40% of users operated CGMs without adequate guidance. Additionally, over half of CGM-related adverse event reports between 2019 and 2021 were attributed to user error rather than device failure, reinforcing the need for structured training programs.

The UAE's annual diabetes conferences further highlight the region's commitment to advancing diabetes care. The 2024 event, co-hosted by the Imperial College London Diabetes Centre and HealthPlus, drew over 400 professionals and emphasized CGM innovations and practical applications. It fostered dialogue on new management strategies, from low-calorie diets to artificial pancreases, reinforcing the role of CGMs in modern diabetes treatment.

In H2 2024, the World Diabetes Foundation (WDF) approved seven ambitious projects focused on expanding non-communicable disease (NCD) prevention and primary care across Africa, the Middle East, North Africa, and South-East Asia. These initiatives are significantly contributing to the growth of the continuous glucose monitoring (CGM) devices market by enhancing healthcare infrastructure and expanding access to diabetes care.

Middle East & Africa Continuous Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East & Africa continuous glucose monitoring devices market report based on type, connectivity, indication, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Standalone CGM Devices
  • Integrated CGM-Insulin Pump Systems
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Bluetooth
  • 4G/Cellular
  • NFC (Near Field Communication)
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Homecare / Personal Use
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Rest of Middle East & Africa
Product Code: GVR-4-68040-642-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Connectivity Segment
    • 1.2.3. Indication Segment
    • 1.2.4. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Middle East & Africa Continuous Glucose Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Middle East & Africa Continuous Glucose Monitoring Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Type Movement Analysis
  • 4.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Device Type, 2021 to 2033 (USD Million)
  • 4.4. Standalone CGM Devices
    • 4.4.1. Standalone CGM Devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Integrated CGM-Insulin Pump Systems
    • 4.5.1. Integrated CGM-Insulin Pump Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Middle East & Africa Continuous Glucose Monitoring Devices Market: Connectivity Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Connectivity Movement Analysis
  • 5.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
  • 5.4. Bluetooth
    • 5.4.1. Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. 4G/Cellular
    • 5.5.1. 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. NFC (Near Field Communication)
    • 5.6.1. NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Middle East & Africa Continuous Glucose Monitoring Devices Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Indication Movement Analysis
  • 6.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by Patient Type, 2021 to 2033 (USD Million)
  • 6.4. Type 1 Diabetes
    • 6.4.1. Type 1 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Type 2 Diabetes
    • 6.5.1. Type 2 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Middle East & Africa Continuous Glucose Monitoring Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Middle East & Africa Continuous Glucose Monitoring Devices Market End Use Movement Analysis
  • 7.3. Middle East & Africa Continuous Glucose Monitoring Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Homecare / Personal Use
    • 7.5.1. Homecare / Personal Use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Middle East & Africa Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Middle East & Africa Continuous Glucose Monitoring Devices Market movement analysis
  • 8.3. Middle East & Africa Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 8.4.1. Middle East & Africa
    • 8.4.2. Middle East & Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. South Africa
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. South Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Saudi Arabia
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. Saudi Arabia Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. UAE
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. UAE Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Kuwait
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Kuwait Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Dexcom, Inc
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Abbott Laboratories
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Medtronic plc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Senseonics Holdings, Inc
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. F. Hoffmann-La Roche (Roche Diabetes Care)
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Ypsomed AG
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. GlySens Incorporated
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Novo Nordisk A/S
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Ascensia Diabetes Care
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Diabetes Cloud (Aidex) and Meiqi (emerging startups)
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
Product Code: GVR-4-68040-642-9

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Middle East & Africa Continuous Glucose Monitoring Devices Market by Country, 2021 - 2033 (USD Million)
  • Table 4 Middle East & Africa Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
  • Table 5 Middle East & Africa Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
  • Table 6 Middle East & Africa Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
  • Table 7 Middle East & Africa Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
  • Table 8 South Africa Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
  • Table 9 South Africa Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
  • Table 10 South Africa Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
  • Table 11 South Africa Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
  • Table 12 Saudi Arabia Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
  • Table 13 Saudi Arabia Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
  • Table 14 Saudi Arabia Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
  • Table 15 Saudi Arabia Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
  • Table 16 UAE Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
  • Table 17 UAE Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
  • Table 18 UAE Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
  • Table 19 UAE Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)
  • Table 20 Kuwait Continuous Glucose Monitoring Devices Market by Type, 2021 - 2033 (USD Million)
  • Table 21 Kuwait Continuous Glucose Monitoring Devices Market by Connectivity, 2021 - 2033 (USD Million)
  • Table 22 Kuwait Continuous Glucose Monitoring Devices Market by Indication, 2021 - 2033 (USD Million)
  • Table 23 Kuwait Continuous Glucose Monitoring Devices Market by End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Europe orthokeratology lens market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Middle East & Africa CGM devices market, type outlook key takeaways (USD Million)
  • Fig. 12 Middle East & Africa CGM devices market type movement analysis 2024 & 2033 (USD Million)
  • Fig. 13 Standalone CGM devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Integrated CGM-insulin pump systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Middle East & Africa CGM devices market, connectivity outlook key takeaways (USD Million)
  • Fig. 16 Middle East & Africa CGM devices market connectivity movement analysis 2024 & 2033 (USD Million)
  • Fig. 17 Bluetooth market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 4G/Cellular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 NFC (Near Field Communication) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Middle East & Africa CGM devices market, indication outlook key takeaways (USD Million)
  • Fig. 21 Middle East & Africa CGM devices market indication movement analysis 2024 & 2033 (USD Million)
  • Fig. 22 Type 1 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Type 2 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Middle East & Africa CGM devices market, end-use outlook key takeaways (USD Million)
  • Fig. 25 Middle East & Africa CGM devices market end-use movement analysis 2024 & 2033 (USD Million)
  • Fig. 26 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Homecare / personal use market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Middle East & Africa CGM devices market, regional key takeaways (USD Million)
  • Fig. 30 Middle East & Africa CGM devices market regional outlook, 2024 & 2033
  • Fig. 31 Middle East & Africa CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 South Africa CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Saudi Arabia CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 UAE CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Kuwait CGM devices market estimates and forecasts, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!